AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Kidney Function Decline among HIV-infected Thai Adults: What are contributing factors?View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Kidney Function Decline among HIV-infected Thai Adults: Is Low Vitamin D one of the Factors?View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Factors Associated with High Cardiovascular Risk among HIV Infected Patients on Antiretroviral Therapy in Tertiary Hospital in IndonesiaView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Smoking Cessation Program for People Who Are Living with HIV: Risk Score Reduction for Coronary Heart DiseaseView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Hepatotoxicity of once-daily tenofovir, lamivudine, and efavirenz regimen assessed among MSM HIV infected patients in ChinaView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment naïve HIV-1 infected adultsView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019High survival rate of HIV -infected patients who receiving Free Antiretroviral Treatment in Beijing, China: A ten-year retrospective cohort studyView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Effectiveness and tolerability of lopinavir/ritonavir plus two NRTIs in HIV-1-infected patients with initial antiretroviral therapy at the Beijing Youan Hospital: a retrospective studyView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Impact of LPV/r- based antiretroviral regimens on lipid profiles in Chinese HIV/AIDS patients in a tertiary hospital in BeijingView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Parthenium hysterophorus Leaf Extracts contains Inhibitory Potential of HIV-RT ActivityView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Cost-effectiveness of direct-acting antivirals (DAAs) compared to pegylated interferon (PegIFN) with ribavirin (RBV) in previously untreated hepatitis C virus genotype 1 (GT1) infected patients without advanced liver disease in Hong KongView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Care Cascade of HCV infection among HIV-infected patients in TaiwanView Abstract
